As interest in neuromuscular activation tools accelerates across elite sport, Control Bionics Limited (ASX:CBL) is positioning itself to capture a growing performance market by moving to acquire full ownership of Neuro Elite Athletics, the U.S. group behind the NeuroBounce program. The company has been building an adjacent footprint in athletic performance through electromyography (EMG)-driven technology,
Read More
Australia’s data-centre construction sector continues to surge on the back of cloud adoption, AI-driven computing needs and hyperscale investment. NSW remains the country’s dominant hub, making it a key battleground for contractors seeking scale, capability and recurring mission-critical work. Against this backdrop, SKS Technologies Group (ASX:SKS) has moved to deepen its position in the state,
Read More
A major Australian research initiative is set to push forward global understanding of brain injury, with Monash University selecting HITIQ’s PROTEQT™ instrumented mouthguard technology for a prestigious Australian Research Council (ARC) Discovery Project. The $799,866 grant will fund a study that aims to define the thresholds at which repeated head impacts cause brain injury –
Read More
Following a successful FY25 which saw a boost in gross profit after launching its refurbished technology division, Harris Technology (ASX: HT8) has started FY26 with strong momentum, propelled by the addition of Apple products to its refurbished portfolio. For the quarter ending 30 September 2025, the online retailer reported $3.8 million in sales – a
Read More
Pivotal Metals (ASX:PVT) has locked in $5.4 million in fresh funding to accelerate exploration across its 100%-owned Quebec copper portfolio, in what Managing Director Ivan Fairhall calls a “transformational milestone” for the company. “This is a transformational milestone for Pivotal, and a significant validation for our Quebec project portfolio,” Fairhall said. “Our Belleterre project hosts
Read More
Biotech company Biotron Limited (ASX:BIT) has announced a bold step into the anaesthetics sector, acquiring Sedarex Limited, a private company developing a next-generation general anaesthetic, alongside a $2.5 million capital raising to support the deal and future development. The move positions Biotron in a multi-billion-dollar global anaesthetics market – one increasingly focused on safer, more
Read More
